Recursion Pharmaceuticals, Inc.

RXRX

Generative AIPrecision medicineBiotech & pharmaceuticals

$4.36vs prev close▲+0.41(+10.38%)

$2.7752W Range$7.18

36% from low

+1.12 (+34.57%)Past 1M

Price

ARK Trade PatternPREMIUM

1M Trades

3 buys

Concentrated buys

1M net buy

+$16.7M

≈ +3.7M shares

Portfolio Weight

1.18%

1M +0.32%p

Holding ETFs

2 ETFs

ARKG · ARKK

Buy · Weight Up

ARK net-bought the stock and the price rose, increasing its portfolio weight.

Shares +25.8% · Market value +74.8% · Weight +0.32%p

Trade Intensity

Concentrated buys

Basis: 0 sells · 3 buys in 1M · Multi-ETF simultaneous buy · weight +0.32%p increase

Trade Log3-day BUY streak

Date	Action	ETF	Shares	Close	Est. total
26.10.07	BUY	ARKG · ARKK	1,880,067	$4.27	$8.0M
26.10.06	BUY	ARKG · ARKK	340,317	$4.63	$1.6M
26.10.05	BUY	ARKG · ARKK	1,482,357	$4.78	$7.1M
26.07.14	BUY	ARKG	14,897	$3.34	$49.8K
26.07.13	BUY	ARKG · ARKK	132,372	$3.30	$436.8K
26.07.10	BUY	ARKG · ARKK	249,223	$3.56	$887.2K
26.07.09	BUY	ARKG · ARKK	23,335	$3.76	$87.7K
26.07.08	BUY	ARKG · ARKK	24,874	$3.72	$92.5K
26.07.07	BUY	ARKG · ARKK	16,650	$3.84	$63.9K
26.07.06	BUY	ARKG · ARKK	9,964	$3.96	$39.5K
26.07.02	BUY	ARKG · ARKK	16,099	$3.80	$61.2K
26.07.01	BUY	ARKG · ARKK	97,833	$3.67	$359.0K
26.06.30	BUY	ARKG · ARKK	605,171	$3.67	$2.2M
26.06.29	BUY	ARKG · ARKK	216,170	$3.69	$797.7K
26.06.26	BUY	ARKG · ARKK	609,643	$3.52	$2.1M

10.07BUY

1,880,067

ARKG · ARKKClose$4.27Est. total$8.0M

10.06BUY

340,317

ARKG · ARKKClose$4.63Est. total$1.6M

10.05BUY

1,482,357

ARKG · ARKKClose$4.78Est. total$7.1M

07.14BUY

14,897

ARKGClose$3.34Est. total$49.8K

07.13BUY

132,372

ARKG · ARKKClose$3.30Est. total$436.8K

07.10BUY

249,223

ARKG · ARKKClose$3.56Est. total$887.2K

07.09BUY

23,335

ARKG · ARKKClose$3.76Est. total$87.7K

07.08BUY

24,874

ARKG · ARKKClose$3.72Est. total$92.5K

07.07BUY

16,650

ARKG · ARKKClose$3.84Est. total$63.9K

07.06BUY

9,964

ARKG · ARKKClose$3.96Est. total$39.5K

07.02BUY

16,099

ARKG · ARKKClose$3.80Est. total$61.2K

07.01BUY

97,833

ARKG · ARKKClose$3.67Est. total$359.0K

06.30BUY

605,171

ARKG · ARKKClose$3.67Est. total$2.2M

06.29BUY

216,170

ARKG · ARKKClose$3.69Est. total$797.7K

06.26BUY

609,643

ARKG · ARKKClose$3.52Est. total$2.1M

1 / 13

Prices estimated from market closing prices on trade dates. Actual execution prices may differ. This is not investment advice.

Stock Timeline

Institutional Holders

1 Holding · 0 Sold · Q4 2025

Based on ARK ETF real-time + 13F quarterly filings

Cathie WoodARK Invest

LIVE

42,794,848

Portfolio Weight

1.18%

in ETF 2.91%

Est. Value

$205M

30D Net

+$17M

13F data may be delayed up to 90 days.

Market Context

Analyst Consensus

※ Analyst opinions are for reference only and do not constitute investment advice. Each securities firm may have different opinions.

Overall Opinion

None

Strong Buy

Buy

Hold

Analyst Targets

avg.

$7.22

vs Current ▲ +65.5% upside

Current$4.36

Low ~ High$4.00 ~ $10.00

Firm

Position

Price Target

Upside / Downside

Close Price

Action

Date

Morgan Stanley

Equal-Weight

$5.50

+26.15%

—

Maintain

2026-05-14

Needham

Buy

$8.00

+83.49%

—

Maintain

2026-05-07

JP Morgan

Overweight

$10.00

+129.36%

—

Maintain

2026-04-30

B of A Securities

Neutral

$6.00

+37.61%

—

Maintain

2026-02-26

Needham

Buy

$8.00

+83.49%

—

Maintain

2026-02-26

1 / 4

Avg Target

$7.22

vs Current ▲ +65.5% upside

None

7 analysts

Strong Buy 2Buy 1Hold 4

Low $4.00

Current $4.36

High $10.00

Firm	Position	Target	Upside	Close	Action	Date
Morgan Stanley	Equal-Weight	$5.50	+26.15%	—	Maintain	26.05.14
Needham	Buy	$8.00	+83.49%	—	Maintain	26.05.07
JP Morgan	Overweight	$10.00	+129.36%	—	Maintain	26.04.30
B of A Securities	Neutral	$6.00	+37.61%	—	Maintain	26.02.26
Needham	Buy	$8.00	+83.49%	—	Maintain	26.02.26

1 / 4

Price Information

Previous Close$3.95

Open$4.01

Day Range$3.89 - $4.43

52-Week Range$2.77 - $7.18

1-Year Change-21.16%

Trading Volume

Volume35,501,287

Avg Volume (3mo)20,926,335

Valuation

Market Cap2.3B

Book Value$1.71

Shares Outstanding535,342,170

Financials

Revenue (TTM)54.9M

Net Income-518,884,000

EPS$-1.00

EBITDA-471,604,000

Profitability

P/E Ratio-

P/B Ratio2.55

Return on Equity (ROE)-56.58%

Return on Assets (ROA)-27.33%

Profit Margin0.00%

EV/EBITDA-3.93

Beta1.03

Dividend

Dividend Rate-

Dividend Yield0.00%

Technical

RSI(14)56.00

Company Overview

Recursion Pharmaceuticals is a clinical-stage biotechnology company that industrializes drug discovery by integrating technology across biology, chemistry, and data science. They are developing multiple drug candidates for various diseases, including cerebral cavernous malformation, neurofibromatosis type 2, and certain cancers. Recursion partners with major pharmaceutical companies to advance its pipeline.

P/B

2.55

Price-to-Book

ROE

-56.6%

Persistent loss

Beta

1.03

Market Volatility

RSI(14)

56.0

Neutral zone

AI-generated summary. Not investment advice.

Recursion Pharmaceuticals, Inc.

Analyst Consensus

Price Information

Trading Volume

Valuation

Financials

Profitability

Dividend

Technical

Related ARK stocks